Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

31 projects found matching your search criteria :

  1. Lyn tyrosine kinase as regulator of lipopolysaccharide-triggered TLR4 pro-inflammatory signaling

    Call: PRELUDIUM 7 , Panel: NZ3

    Principal investigator: dr Kinga Borzęcka-Solarz

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  2. Inhibition of p21-Activated Kinase (PAK) as a new molecular target in the treatment of chronic myeloid leukemia (CML)

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Flis

    Narodowy Instytut Leków

  3. Mechanism regulating vitamin D analog cooperation with cytostatics and tyrosine kinase inhibitors in non-small cell lung...

    Call: PRELUDIUM 5 , Panel: NZ4

    Principal investigator: dr Ewa Agnieszka Maj

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  4. Polymorphic pre-miR-146a and synergistic action of all of its products on NTRK2 gene in Papillary Thyroid Carcinoma

    Call: PRELUDIUM 4 , Panel: NZ2

    Principal investigator: dr Anna Kubiak

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  5. Protein tyrosine phosphatases inhibition as a strategy against infectious diseases and bioterrorism

    Call: PRELUDIUM 4 , Panel: NZ1

    Principal investigator: dr Alicja Kuban-Jankowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  6. Förster Resonance Energy Transfer (FRET) analysis between fluorescently active components present in sweat-fat substance...

    Call: PRELUDIUM 24 , Panel: ST4

    Principal investigator: Emilia Weronika Gruszczyńska

    Uniwersytet Gdański

  7. Novel insights into inhibition of PD-L1/PD-1 immune checkpoint – discovery and optimization of covalent PD-L1 inhibitors...

    Call: SONATA 20 , Panel: ST5

    Principal investigator: dr Radosław Dariusz Kitel

    Uniwersytet Jagielloński

  8. Analysis of pharmacokinetic, pharmacodynamic and molecular determinants of intolerance and resistance to the Janus kinas...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Marta Katarzyna Karaźniewicz-Łada

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  9. Zn2+-dependent competition between CD4 and CD8α coreceprtor for Lck tyrosine kinase

    Call: SONATA 19 , Panel: NZ1

    Principal investigator: dr Anna Marta Kocyła

    Uniwersytet Wrocławski, Wydział Biotechnologii

  10. Novel aspects of the mechanisms of vascular toxicity of tyrosine kinase inhibitors: studies on their proinflammatory act...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Tomasz Krzysztof Prajsnar

    Uniwersytet Jagielloński, Wydział Biologii

  11. Investigating the mechanisms of CD20 downregulation triggered by tyrosine kinase inhibitors in Philadelphia chromosome-p...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Krzysztof Domka

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  12. INVADOPODIA IN AXL-DRIVEN CANCER INVASION AND DRUG RESISTANCE

    Call: OPUS 25 , Panel: NZ3

    Principal investigator: dr Daria Paulina Zdżalik-Bielecka

    Uniwersytet Warszawski, Wydział Biologii

  13. Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier in...

    Call: POLONEZ BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Aneta Iwona Radziwon-Balicka

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  14. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  15. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  16. AXL receptor signaling in cancer cell growth and drug resistance

    Call: OPUS 20 , Panel: NZ3

    Principal investigator: prof. Marta Elżbieta Miączyńska

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  17. Iron chelators as tyrosine kinase inhibitors - a new strategy for the treatment of glioblastoma multiforme

    Call: PRELUDIUM BIS 2 , Panel: NZ5

    Principal investigator: dr hab. Anna Dominika Mrozek-Wilczkiewicz

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

  18. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kucińska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  19. Tyrosine-modified polyethylenimine polymers as a promising vectors for siRNA delivery in synergistic cancer immunotherap...

    Call: PRELUDIUM 19 , Panel: NZ5

    Principal investigator: Małgorzata Kubczak

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  20. Comparative evaluation of effects of tyrosine kinase inhibitors (TKIs) on endothelial function in vivo in mice

    Call: PRELUDIUM 17 , Panel: NZ5

    Principal investigator: Brygida Elżbieta Marczyk

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  21. Inhibition of tyrosine phosphatase as a strategy to enhance insulin sensitivity through activation of chaperone mediated...

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: dr hab. Krzysztof Marycz

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt

  22. Insights into biological activity and mechanism of action of novel styrylquinazoline derivatives as tyrosine kinase inhi...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Katarzyna Anna Malarz

    UNIWERSYTET ŚLĄSKI, Wydział Matematyki, Fizyki i Chemii

  23. Qualitative and functional analysis of nitrated beta-1,3-glucanase in resistance of potato leaves to Phythophthora infes...

    Call: PRELUDIUM 12 , Panel: NZ9

    Principal investigator: Karolina Izbiańska

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  24. The role of tyrosine phosphorylation in posttranslational processing and secretion of major virulence factors of Porphyr...

    Call: PRELUDIUM 12 , Panel: NZ1

    Principal investigator: dr Zuzanna Maria Nowakowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  25. The role of nitric oxide as compound improving ability to germination of apple embryos isolated from warm statified seed...

    Call: OPUS 12 , Panel: NZ9

    Principal investigator: dr hab. Urszula Krasuska

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

  26. The role of superoxide dysmutase and glutathione in response to phytotoxycity of meta-tyrosine

    Call: PRELUDIUM 12 , Panel: NZ9

    Principal investigator: dr Olga Agata Andrzejczak

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Wydział Rolnictwa i Biologii

  27. Impact of palmitoylation on the Zn(II)-dependent interaction between CD4 coreceptor and Lck tyrosine kinase.

    Call: PRELUDIUM 11 , Panel: NZ1

    Principal investigator: Anna Marta Kocyła

    Uniwersytet Wrocławski, Wydział Biotechnologii

  28. Analysis of the effectiveness of anticancer activity of tyrosine kinase inhibitors combined with nanoparticles in in vit...

    Call: SONATA 11 , Panel: ST4

    Principal investigator: dr Natalia Piergies

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

  29. Endocytosis of AXL receptor and its role in AXL-mediated signaling.

    Call: SONATA 10 , Panel: NZ3

    Principal investigator: dr Daria Paulina Zdżalik-Bielecka

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  30. New MOF compounds as degradable nanocontainers of tyrosine kinases inhibitors in novel anti-cancer therapy

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Artur Piotr Terzyk

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

  31. Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h...

    Call: PRELUDIUM 9 , Panel: NZ5

    Principal investigator: Zofia Felicja Bielecka

    Wojskowy Instytut Medyczny